Condition: Nasopharyngeal Carcinoma · Sponsor: Sun Yat-sen University
The purpose of this study is to determine whether concurrent chemotherapy and IMRT is effective in the treatment of locally stage T3/T4 recurrent nasopharyngeal carcinoma patients compared with IMRT alone.
This description comes directly from the study's public registry record.
Fei Han, doctor · 8620-87343030 · hanfei@sysucc.org.cn
hanyu wang, doctor · 8620-87343418 · wanghany@sysucc.org.cn
Always discuss trial participation with your own doctor first.
| WangHanYu | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04136886